Brevan Howard Capital Management LP Harrow Health, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 29,266 shares of HROW stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,266
Previous 18,946
54.47%
Holding current value
$1.19 Million
Previous $578,000
138.58%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HROW
# of Institutions
218Shares Held
21.7MCall Options Held
998KPut Options Held
593K-
Opaleye Management Inc. Boston, MA3.91MShares$159 Million30.67% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$87.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$76.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.86MShares$75.6 Million9.42% of portfolio
-
State Street Corp Boston, MA794KShares$32.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.1B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...